
Biossil hits $1B valuation after OpenAI-led $153M round to revive failed drugs
Biossil raises $153M led by OpenAI to resurrect abandoned drug candidates using AI, hitting $1B valuation.
News, trends, and insights from the AI frontier.
Latest Anthony Mouchantaf coverage.